Related Experiment Video
Updated: Jul 8, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
Richard Musil1, Ilja Spellmann, Michael Riedel
1Psychiatric Clinic of University Munich, Nussbaumstrasse 7, 80336 Munich, Germany. Richard.musil@med.uni-muenchen.de
Genetic variations in the synaptosomal-associated protein of 25kDa (SNAP-25) gene are linked to weight gain in patients taking atypical antipsychotics. This study partly replicates previous findings on SNAP-25 polymorphisms and antipsychotic-induced weight changes.
Area of Science:
- Neuroscience
- Pharmacogenetics
- Genetics
Background:
- Atypical antipsychotics can cause significant weight gain, a serious side effect impacting patient adherence and health.
- Genetic factors influence appetite regulation and may predispose individuals to antipsychotic-induced weight gain.
- Previous research suggested a link between synaptosomal-associated protein of 25kDa (SNAP-25) gene polymorphisms and weight changes during antipsychotic treatment.
Purpose of the Study:
- To investigate the association between three specific polymorphisms in the SNAP-25 gene (MnlI, TaiI, and DdelI) and weight gain in patients treated with atypical antipsychotics.
- To replicate preliminary findings on the impact of SNAP-25 gene polymorphisms on clinical response and weight gain.
- To explore the relationship between these SNAP-25 polymorphisms and baseline serum triglyceride levels.
Main Methods:
- Genotyping of 162 schizophrenic patients on atypical antipsychotic monotherapy and 312 healthy controls for three SNAP-25 polymorphisms using PCR.
- Weekly assessment of Positive and Negative Syndrome Scale (PANSS) scores and body weight for at least five weeks.
- Analysis of associations between SNAP-25 polymorphisms, weight gain, and baseline serum triglyceride levels.
Main Results:
- Significant associations were found between the TaiI and MnlI SNAP-25 polymorphisms and baseline serum triglyceride levels.
- The DdelI SNAP-25 polymorphism showed a significant association with antipsychotic-induced weight gain.
- These findings provide partial replication of previous research linking SNAP-25 gene variations to weight changes.
Conclusions:
- Specific polymorphisms in the SNAP-25 gene, particularly DdelI, are associated with weight gain in patients receiving atypical antipsychotics.
- The study partially confirms the role of SNAP-25 gene variations in modulating weight gain during antipsychotic therapy.
- These findings underscore the potential of pharmacogenetics in predicting and managing antipsychotic-induced weight gain.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Single Nucleotide Polymorphisms-SNPs
Psychological and Sociocultural Causes of Schizophrenia